Discover
KYMR
Kymera Therapeutics, Inc.
114.20
2 x 83.05
2 x 145.93
bid
ask
-
0.47
0.41%
2 @ 05:24 AM
113.96 -0.24 (0.21%)
| Ytd | 46.77% | |
| 1y | 156.98% |
112.28
day range
116.75
36.65
52 week range
130.05
| Open | 114.29 | Prev Close | 114.67 | Low | 112.28 | High | 116.75 | Mkt Cap | 9.39B |
| Vol | 862.39K | Avg Vol | 762.83K | EPS | -3.57 | P/E | N/A | Forward P/E | -26.28 |
| Beta | 2.03 | Short Ratio | 17.34 | Inst. Own | 112.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 86.26 | 200-d Avg | 76.09 | 1yr Est | 123.76 |
| Income Statement | |||
| Total Revenue | 34.37M | ||
| Revenues (USD) | 34.37M | ||
| Gross Profit | 34.37M | ||
| Operating Expenses | 118.52M | ||
| Research and Development Expense | 98.16M | ||
| Selling, General and Administrative Expense | 20.36M | ||
| Operating Income | -84.15M | ||
| Interest Expense | 61.00K | ||
| Net Income | -69.23M | ||
| Net Income Common Stock | -69.23M | ||
| Net Income Common Stock (USD) | -69.23M | ||
| Consolidated Income | -69.23M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -69.17M | ||
| Earning Before Interest & Taxes (USD) | -69.17M | ||
| Weighted Average Shares | 97.53M | ||
| Weighted Average Shares Diluted | 97.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 149.90M | ||
| Cash and Equivalents (USD) | 149.90M | ||
| Investments | 1.40B | ||
| Investments Current | 506.84M | ||
| Investments Non-Current | 894.72M | ||
| Current Assets | 677.43M | ||
| Property, Plant & Equipment Net | 83.35M | ||
| Total Assets | 1.67B | ||
| Debt Current | 13.73M | ||
| Total Debt | 80.47M | ||
| Current Liabilities | 62.64M | ||
| Debt Non-Current | 66.74M | ||
| Total Liabilities | 129.38M | ||
| Accumulated Retained Earnings (Deficit) | -1.14B | ||
| Accumulated Other Comprehensive Income | -4.19M | ||
| Shareholders Equity | 1.54B | ||
| Shareholders Equity (USD) | 1.54B | ||
| Assets Non-Current | 991.58M | ||
| Total Debt (USD) | 80.47M | ||
| Liabilities Non-Current | 66.74M | ||
| Trade and Non-Trade Payables | 12.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.02M | ||
| Net Cash Flow from Financing | 18.77M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -212.91M | ||
| Capital Expenditure | -434.00K | ||
| Issuance (Purchase) of Equity Shares | 19.19M | ||
| Issuance (Repayment) of Debt Securities | -425.00K | ||
| Net Cash Flow from Investing | -142.84M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -142.41M | ||
| Net Cash Flow from Operations | -88.84M | ||
| Share Based Compensation | 16.01M | ||